サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1696248

ヒューマンヘルス用クリルオイルの世界市場：2025年～2032年

Global Krill Oil for Human Health Market - 2025-2032

出版日
ページ情報
英文 180 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
ヒューマンヘルス用クリルオイルの世界市場：2025年～2032年
出版日: 2025年03月25日
発行: DataM Intelligence
ページ情報: 英文 180 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のヒューマンヘルス用クリルオイルの市場規模は、2024年に2億9,218万米ドルとなりました。同市場は、2032年には12億8,168万米ドルに達し、2025年から2032年にかけて20.3％のCAGRで拡大すると予測されています。

小型甲殻類由来のクリルオイルは、リン脂質、オメガ3脂肪酸、アスタキサンチンを豊富に含み、心臓血管、認知、関節、皮膚の健康に大きなメリットをもたらします。予防医療への意識の高まり、高齢化社会への懸念、天然サプリメントへの需要が市場成長の原動力となっています。さらに、トリグリセリド値の低下、炎症の抑制、心臓の健康促進におけるクリルオイルの有効性を強調する臨床研究が、世界の普及をさらに後押ししています。

世界の成人の70%が栄養補助食品を毎日摂取していることから、予防ヘルスケアの人気が高まり、クリルオイルの需要を後押ししています。ハーバード大学医学部とNIHの研究によると、クリルオイルの摂取は心臓発作のリスクを25%、脳卒中を20%低減し、HDLコレステロール値を15%改善することが明らかになっています。米国産科婦人科学会（ACOG）は、PMSの症状緩和のためにオメガ3の摂取を支持しており、けいれんや気分の落ち込みが40％減少するといいます。さらに、オメガ3は早産のリスクを10～20％低減させることから、妊産婦の健康への応用も拡大しており、クリルオイルは妊産婦ケアに欠かせないサプリメントとなっています。

クリルオイルは、酸化ストレスに対抗し、肌の保湿を高めるアスタキサンチンを含有するため、スキンケアやアンチエイジング製品の重要な成分となっています。2023年に行われたDSM Nutritional Productsの試験では、12週間のクリルオイルの補給で小ジワが20％減少し、肌の保湿が30％改善しました。Journal of Cosmetic Dermatologyに掲載された研究では、クリルオイルが肌の弾力性とバリア機能を高めることが示されており、北米や欧州の美容サプリメントで人気の成分となっています。ノルウェーのブランドNYO3は、コラーゲンとヒアルロン酸を配合したクリルオイルを発売し、中国の女性用スキンケア分野をターゲットにしています。

心血管の健康に対する意識の高まりは、クリルオイル市場の主な促進要因です。クリルオイルに含まれるオメガ3脂肪酸は、心臓病リスクの低減に役立つとして米国心臓協会（AHA）などの団体から支持されています。JAMA Network Openに掲載されたMozaffarianらによる最近の研究では、クリルオイルが心臓病予防の重要な指標であるトリグリセリド値を有意に低下させることが確認されました。さらに、ハーバード大学医学部が2023年に行った調査では、オメガ3を定期的に補給することで、心臓発作のリスクが25％、脳卒中のリスクが20％低下することが実証されました。

クリルオイルの大手メーカーであるAker BioMarineによる臨床試験では、毎日のクリルオイル摂取が脂質レベルと血圧を低下させ、心臓の健康をさらにサポートすることが強調されています。心血管疾患が依然として世界の死亡原因のトップであることから、消費者は予防のためにクリルオイルのような天然サプリメントを求めるようになっています。この需要は、クリルオイル使用者のHDL（善玉）コレステロール値が15％改善したことを報告した米国立衛生研究所（NIH）の研究など、政府が資金を提供する健康イニシアチブによってさらに支えられています。こうした知見は、クリルオイルを心臓の健康におけるゲームチェンジャーとして確固たるものにし、その普及拡大に貢献しています。

健康上の利点があるにもかかわらず、クリルオイル市場は持続可能性と規制当局の承認に関する課題に直面しています。クリルは海洋生態系の重要な構成要素であり、クジラ、アザラシ、ペンギンなどの海洋生物の主要な食料源となっています。乱獲の懸念から、特にクリルオイルの大半を供給している南極地域では厳しい捕獲規制が敷かれています。南極海洋生物資源保全委員会（CCAMLR）のような組織は、オキアミの個体数の枯渇を防ぐために漁獲枠を設定し、供給量の増加を制限しています。

当レポートでは、世界のヒューマンヘルス用クリルオイル市場について調査し、市場の概要とともに、形態別、用途別、販売チャネル別、地域別動向、競合情勢、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
    • 抑制要因
    • 機会
    • 影響分析

第5章 業界分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • 持続可能な分析
  • DMIオピニオン

第6章 形態別

  • カプセル
    • ソフトジェル
    • ハードジェル
  • オイル
  • 粉末
  • グミ

第7章 用途別

  • 心臓血管の健康
    • 循環改善
    • 心臓発作と脳卒中
    • その他
  • 一般的な栄養と健康
  • 女性の健康
    • 月経前症候群
    • 生理痛
    • 出生前
    • その他
  • 関節と骨の健康
    • 変形性関節症
    • 骨粗鬆症
    • 関節の痛みと炎症
    • その他
  • 神経学の健康
    • 認知
    • メンタルヘルス
    • その他
  • 肌の健康
    • アンチエイジング
    • 水分補給と弾力性
    • その他
  • 目の健康
    • ドライアイ
    • 炎症
    • その他
  • その他

第8章 販売チャネル別

  • B2B
  • B2C

第9章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他
  • 南米
    • ブラジル
    • アルゼンチン
    • その他
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他
  • 中東・アフリカ

第10章 競合情勢

  • 競合シナリオ
  • 市場ポジショニング/シェア分析
  • 合併と買収の分析

第11章 企業プロファイル

  • AKER BIOMARINE
  • Biocorp Co., Ltd.
  • Rimfrost AS
  • Shandong Kangjing Marine Biotechnology Co., Ltd

第12章 付録

目次
Product Code: FB9409

Global krill oil for human health market was valued at US$ 292.18 million in 2024 and is expected to reach US$ 1,281.68 million by 2032, growing with a CAGR of 20.3% between 2025 and 2032.

Krill oil, derived from small crustaceans, is rich in phospholipids, omega-3 fatty acids, and astaxanthin, offering significant cardiovascular, cognitive, joint, and skin health benefits. Increasing awareness of preventive healthcare, aging population concerns, and demand for natural supplements is driving the market growth. Additionally, clinical studies highlighting krill oil's effectiveness in reducing triglyceride levels, inflammation, and promoting heart health have further fueled its adoption worldwide.

Market Trends

Rising Demand for Preventive Healthcare and Functional Nutrition

With 70% of adults globally consuming dietary supplements daily, preventive healthcare is gaining traction, boosting demand for krill oil. Harvard Medical School and NIH studies reveal that krill oil consumption can reduce heart attack risks by 25% and strokes by 20%, while also improving HDL cholesterol levels by 15%. The American College of Obstetricians and Gynecologists (ACOG) supports omega-3 intake for PMS symptom relief, with a 40% reduction in cramps and mood swings. Furthermore, prenatal health applications are growing, as omega-3s help reduce preterm birth risks by 10-20%, making krill oil a critical supplement for maternal care.

Expansion in Skincare and Anti-Aging Products

Krill oil is becoming a key ingredient in skincare and anti-aging products due to its astaxanthin content, which combats oxidative stress and enhances skin hydration. A 2023 DSM Nutritional Products trial found that 12 weeks of krill oil supplementation reduced fine wrinkles by 20% and improved skin hydration by 30%. Studies published in the Journal of Cosmetic Dermatology show krill oil enhances skin elasticity and barrier function, making it a sought-after ingredient in North American and European beauty supplements. Norwegian brand NYO3 is launching krill oil with collagen and hyaluronic acid, targeting the women's skincare segment in China.

Market Dynamics

Market Driver: Growing Awareness of Cardiovascular Benefits

The rising awareness of cardiovascular health is a major driver of the krill oil market. Omega-3 fatty acids found in krill oil have been endorsed by organizations like the American Heart Association (AHA) for their role in reducing heart disease risks. A recent study by Mozaffarian et al., published in JAMA Network Open, confirmed that krill oil significantly reduces triglyceride levels, a key marker for heart disease prevention. Additionally, research conducted by Harvard Medical School in 2023 demonstrated that regular omega-3 supplementation lowers the risk of heart attacks by 25% and strokes by 20%.

Clinical trials by Aker BioMarine, a leading krill oil manufacturer, highlight that daily krill oil intake reduces lipid levels and blood pressure, further supporting heart health. Given that cardiovascular diseases remain the leading cause of mortality worldwide, consumers are increasingly seeking natural supplements like krill oil for preventive care. The demand is further supported by government-funded health initiatives, such as the National Institutes of Health (NIH) study, which reported a 15% improvement in HDL (good) cholesterol levels among krill oil users. These findings solidify krill oil as a game-changer in heart health and contribute to its growing adoption.

Market Restraint: Sustainability Concerns and Regulatory Challenges

Despite its health benefits, the krill oil market faces challenges related to sustainability and regulatory approvals. Krill is a vital component of the marine ecosystem, serving as the primary food source for marine species like whales, seals, and penguins. Overfishing concerns have led to strict harvesting regulations, particularly in the Antarctic region, where the majority of krill oil is sourced. Organizations like the Commission for the Conservation of Antarctic Marine Living Resources (CCAMLR) have imposed quotas to prevent depletion of krill populations, restricting supply growth.

Segment Analysis

Capsule Form Dominates Market due to its Convenience, Extended Shelf Life

Capsules are preferred over liquid and soft gel forms because they ensure precise dosage, minimal oxidation, and higher bioavailability. Unlike fish oil, krill oil is naturally bound to phospholipids, which enhance omega-3 absorption in the body. Clinical studies indicate that krill oil capsules are 2.5 times more bioavailable than traditional fish oil capsules.

Consumer preference for on-the-go supplements is driving demand for capsule-based formulations, particularly among working professionals and the elderly. Brands like Kori Krill Oil and Aker BioMarine are launching advanced formulations, including krill oil capsules infused with turmeric, B12, and plant-based antioxidants, catering to holistic wellness needs.

Additionally, pharmaceutical and nutraceutical companies are expanding their capsule-based product portfolios to address various health concerns such as joint health, heart health, cognitive function, and skincare. The rise of e-commerce and direct-to-consumer sales channels has further accelerated the adoption of krill oil capsules, making them the fastest-growing segment in the global krill oil market.

Geographical Penetration

North America is the largest and fastest-growing market for krill oil, driven by high consumer awareness, strong demand for dietary supplements, and a growing aging population. The US and Canada account for a significant share due to their proactive health-conscious populations. According to Harvard Medical School, over 50% of U.S. adults consume omega-3 supplements, with krill oil gaining popularity over traditional fish oil due to its higher bioavailability and antioxidant content.

The American Heart Association (AHA) and the National Institutes of Health (NIH) have endorsed omega-3 fatty acids, further boosting demand. Additionally, the rising prevalence of cardiovascular diseases, which remain the leading cause of death in the U.S., has accelerated the adoption of krill oil supplements.

The North American market is also witnessing innovation in krill oil formulations. Kori Krill Oil introduced Mind & Body supplements, combining krill oil with nootropics and turmeric for cognitive and heart health. Furthermore, e-commerce channels like Amazon and Walmart are fueling online krill oil sales, making it accessible to a wider demographic. With high disposable incomes, advanced healthcare infrastructure, and strong brand presence, North America is expected to maintain its dominant position in the krill oil market.

Competitive Landscape

Segment Structure

By Form

  • Capsules
    • Softgels
    • Hardgels
  • Oil
  • Powder
  • Gummies

By Application

  • Cardiovascular Health
    • Circulation Improvement
    • Heart Attacks and Strokes
    • Others
  • General Nutrition and Wellness
  • Women Health
    • Premenstrual Syndrome
    • Period Pains
    • Prenatal Health
    • Others
  • Joint and Bone Health
    • Osteoarthritis
    • Osteoporosis
    • Join Pains and Inflammation
    • Others
  • Neurology Health
    • Cognition
    • Mental Health
    • Others
  • Skin Health
    • Anti-Aging
    • Hydration and Elasticity
    • Others
  • Eye Health
    • Dry Eye
    • Inflammation
    • Others
  • Others

By Sales Channel

  • B2B
  • B2C

By Region

  • North America
  • South America
  • Europe
  • Asia-Pacific
  • Middle East and Africa

Why Choose DataM Intelligence?

  • Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares, and value chain evaluations, enriched by interviews with industry leaders and disruptors.
  • Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
  • White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
  • Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
  • Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
  • Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Form
  • 3.2. Snippet by Application
  • 3.3. Snippet by Sales Channel
  • 3.4. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Growing Awareness of Cardiovascular Benefits
      • 4.1.1.2. Sustainability Concerns and Regulatory Challenges
    • 4.1.2. Restraints
      • 4.1.2.1. Lack of Awareness
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Sustainable Analysis
  • 5.6. DMI Opinion

6. By Form

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 6.1.2. Market Attractiveness Index, By Form
  • 6.2. Capsules*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 6.2.3. Softgels
    • 6.2.4. Hardgels
  • 6.3. Oil
  • 6.4. Powder
  • 6.5. Gummies

7. By Application

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 7.1.2. Market Attractiveness Index, By Application
  • 7.2. Cardiovascular Health*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
    • 7.2.3. Circulation Improvement
    • 7.2.4. Heart Attacks and Strokes
    • 7.2.5. Others
  • 7.3. General Nutrition and Wellness
  • 7.4. Women's Health
    • 7.4.1. Premenstrual Syndrome
    • 7.4.2. Period Pains
    • 7.4.3. Prenatal Health
    • 7.4.4. Others
  • 7.5. Joint and Bone Health
    • 7.5.1. Osteoarthritis
    • 7.5.2. Osteoporosis
    • 7.5.3. Join Pains and Inflammation
    • 7.5.4. Others
  • 7.6. Neurology Health
    • 7.6.1. Cognition
    • 7.6.2. Mental Health
    • 7.6.3. Others
  • 7.7. Skin Health
    • 7.7.1. Anti-Aging
    • 7.7.2. Hydration and Elasticity
    • 7.7.3. Others
  • 7.8. Eye Health
    • 7.8.1. Dry Eye
    • 7.8.2. Inflammation
    • 7.8.3. Others
  • 7.9. Others

8. By Sales Channel

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 8.1.2. Market Attractiveness Index, By Sales Channel
  • 8.2. B2B*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. B2C

9. By Region

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 9.1.2. Market Attractiveness Index, By Region
  • 9.2. North America
    • 9.2.1. Introduction
    • 9.2.2. Key Region-Specific Dynamics
    • 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.2.6.1. US
      • 9.2.6.2. Canada
      • 9.2.6.3. Mexico
  • 9.3. Europe
    • 9.3.1. Introduction
    • 9.3.2. Key Region-Specific Dynamics
    • 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.3.6.1. Germany
      • 9.3.6.2. UK
      • 9.3.6.3. France
      • 9.3.6.4. Italy
      • 9.3.6.5. Spain
      • 9.3.6.6. Rest of Europe
  • 9.4. South America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Key Region-Specific Dynamics
    • 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.4.7.1. Brazil
      • 9.4.7.2. Argentina
      • 9.4.7.3. Rest of South America
  • 9.5. Asia-Pacific
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel
    • 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 9.5.6.1. China
      • 9.5.6.2. India
      • 9.5.6.3. Japan
      • 9.5.6.4. Australia
      • 9.5.6.5. Rest of Asia-Pacific
  • 9.6. Middle East and Africa
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
    • 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Sales Channel

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. AKER BIOMARINE*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Financial Overview
    • 11.1.4. Key Developments
  • 11.2. Biocorp Co., Ltd.
  • 11.3. Rimfrost AS
  • 11.4. Shandong Kangjing Marine Biotechnology Co., Ltd

LIST NOT EXHAUSTIVE

12. Appendix

  • 12.1. About Us and Services
  • 12.2. Contact Us